SYNT

Synthomer PLC

Chemicals First-pass screen £113m

340/1000 Overall fit

AI beneficiary 35% 25

Operating leverage 25% 50

Valuation 25% 30

Downside protection 15% 37

First-pass take

Synthomer is a specialty chemicals manufacturer with zero AI revenue exposure. Margin improvement (+40bps EBITDA) is cost-driven (£30m self-help), not leverage-based, on declining volume (–10%). Net debt 4.7x EBITDA, loss-making, cyclical end-markets (coatings, construction), and medical gloves division down 17% — high downside risk.

Flags

loss-makinghigh-leveragecyclical-demandno-valuation-datacost-cutting-dependentpost-pandemic-weaknesstariff-exposed